Independent Assessment Committee
|
The Independent Assessment Committee (IAC) is the principal decision-making group regarding the eligibility of a vaccine for the Advance Market Commitment. The IAC is the cornerstone of this process and is responsible for determining the Target Product Profile (TPP) evaluation process. The IAC ensures that the decision of whether a product meets the TPP (and is eligible for AMC funding) is fair, transparent, and credible to all signatories of the Framework Agreement and other stakeholders. Functions of the IAC Expertise Membership The AMC Secretariat is pleased to announce the selection of Claire Broome and Soonman Kwon as the Chairperson and Vice Chairperson respectively of the Independent Assessment Committee (IAC) . As per the IAC Bylaws, the IAC Selection and Oversight Panel was asked to select the IAC Chairperson and Vice Chairperson. The selection was decided on 6th July 2009 and announced to all IAC members on 14th July 2009. In addition, as indicated in the IAC Bylaws, the IAC members were asked to express their preferences with regards to the duration of their membership. Based on those preferences, the AMC Secretariat selected the length of membership as follows:
For more information on the IAC, please see the IAC Charter and Bylaws |
Related DocumentsIAC Members IAC
Selection Process
|





